Literature DB >> 3550767

Liver transplantation today.

J W Marsh, L Makowka, S Todo, R D Gordon, C O Esquivel, A Tzakis, S Iwatsuki, T E Starzl.   

Abstract

In summary, liver transplantation has truly come of age. To put things in perspective, the recipient waiting list at the University of Pittsburgh never includes fewer than 200 suitable candidates, and it continues to grow in spite of the fact that we are now doing essentially one transplant per day. There are many excellent transplant centers throughout the United States and Europe, the only limiting factor being the supply of donors. Orthotopic liver transplantation is now covered by most major health insurance carriers, and some form of government coverage is anticipated for the indigent. As the supply of donors increases with aggressive education programs, the need for transplantation centers will also increase. However, this should not be uncontrolled growth. Mandatory training in transplantation surgery will surely be required as a prerequisite to the establishment of transplant centers in the future. The field of organ transplantation is the newest and most dynamic in medicine today. The results are encouraging and acceptable and offer the only hope to many persons dying of end-stage organ failure. With improvements in immune modulation at hand, organ transplantation will soon become a commonplace procedure offering a completely normal life expectancy.

Entities:  

Mesh:

Year:  1987        PMID: 3550767     DOI: 10.1080/00325481.1987.11699776

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  2 in total

1.  Unusually rapid development of a HBsAG-positive liver cirrhosis after liver transplantation.

Authors:  H U Lautz; R Müller; C Wittekind; S Mauz; H Barg-Hock; B Ringe; R Pichlmayr; F W Schmidt
Journal:  Klin Wochenschr       Date:  1989-10-17

Review 2.  Treatment of inherited metabolic disorders by liver transplantation.

Authors:  M Burdelski; B Rodeck; A Latta; K Latta; J Brodehl; B Ringe; R Pichlmayr
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.